Medivir AB 

€0.151400
0
-€0.01-3.44% Wednesday 06:50

Statistics

Day High
0.1514
Day Low
0.1514
52W High
0.2665
52W Low
0.0037
Volume
-
Avg. Volume
-
Mkt Cap
93.93M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2025
Q1 2026
Q2 2026
Next
-0.03
-0.02
-0.01
0
Expected EPS
-0.008269337272224
Actual EPS
N/A

Financials

-1,106.24%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
780,133.01Revenue
-8.63MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Established in 1987 and headquartered in Huddinge, Sweden, Medivir AB (publ) is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products. Its primary therapeutic area is oncology, with operations extending across Sweden and internationally. The company's marketed product, Zoviduo (also known as Xerclear), treats labial herpes. Medivir's robust pipeline features several investigational compounds: Remetinostat for MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818 for liver cancer; MIV-711 for osteoarthritis; and Birinapant along with IGM-8444, both targeting solid tumors. Furthermore, Medivir engages in strategic collaborations, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS-CoV-2, and has licensing agreements with Tango Therapeutics and Ubiquigent Limited for preclinical research programs, specifically Ubiquigent's USP7 program.
Show more...
CEO
Jens Lindberg
Employees
10
Country
Sweden
ISIN
SE0020181014
WKN
000A3EFZT

Listings

0 Comments

Share your thoughts

FAQ

What is Medivir AB stock price today?
The current price of MVR0.MU is €0.15 EUR — it has decreased by -3.44% in the past 24 hours. Watch Medivir AB stock price performance more closely on the chart.
What is Medivir AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Medivir AB stocks are traded under the ticker MVR0.MU.
Is Medivir AB stock price growing?
MVR0.MU stock has risen by +0% compared to the previous week, the month change is a -9.88% fall, over the last year Medivir AB has showed a -8.9% decrease.
What is Medivir AB market cap?
Today Medivir AB has the market capitalization of 93.93M
When is the next Medivir AB earnings date?
Medivir AB is going to release the next earnings report on November 05, 2026.
What is Medivir AB revenue for the last year?
Medivir AB revenue for the last year amounts to 780,133.01 EUR.
What is Medivir AB net income for the last year?
MVR0.MU net income for the last year is -8.63M EUR.
How many employees does Medivir AB have?
As of September 04, 2026, the company has 10 employees.
In which sector is Medivir AB located?
Medivir AB operates in the Health & Wellness sector.
When did Medivir AB complete a stock split?
Medivir AB has not had any recent stock splits.
Where is Medivir AB headquartered?
Medivir AB is headquartered in Huddinge, Sweden.